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Artiﬁcial membranesThe pore forming toxin Hla (α-toxin) from Staphylococcus aureus is an important pathogenic factor of the bacte-
rium S. aureus and also a model system for the process of membrane-induced protein oligomerisation and pore
formation. It has been shown that binding to lipid membranes at neutral or basic pH requires the presence of a
phosphocholine-headgroup. Thus, sphingomyelin and phosphatidylcholine may serve as interaction partners in
cellular membranes. Based on earlier studies it has been suggested that rafts of sphingomyelin are particularly
efﬁcient in toxin binding. In this study we compared the oligomerisation of Hla on liposomes of various lipid
compositions in order to identify the preferred interaction partners and conditions. Hla seems to have an intrinsic
preference for sphingomyelin compared to phosphatidylcholine due to a higher probability of oligomerisation of
membrane boundmonomer.We also can show that increasing the surface density of Hla-binding sites enhances
the oligomerisation efﬁciency. Thus, preferential binding to lipid rafts can be expected in the cellular context. On
the other hand, sphingomyelin in the liquid disordered phase is a more favourable binding partner for Hla than
sphingomyelin in the liquid ordered phase, whichmakes themembrane outside of lipid rafts themore preferred
region of interaction. Thus, the partitioning of Hla is expected to strongly depend on the exact composition of raft
and non-raft domains in the membrane.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Pore forming toxins play an important role in the attack of target
cells by bacteria and animals. Typically these molecules (peptides or
proteins) are secreted into the surrounding medium as monomers.
Binding of these pathogenic factors disturbs membrane integrity by
formation of a transmembrane pore, in many cases via the assembly
of several toxin molecules to an oligomeric complex. These pores vary
strongly in size, depending on the type of toxin and number of
protomers in the ﬁnal oligomeric structure [1,2]. The initial contact
with the cell membrane is made via certain protein receptors and/or
lipid components, depending on the toxin type and concentration (see
Ref. [2] for an overview). In case of toxin binding to lipid headgroups a
frequently identiﬁed receptor structure is the phosphocholine (POC)
headgroup which is abundant on the outer leaﬂet of the plasma mem-
brane in form of unsaturated phosphatidylcholine (PC) and saturatedgiant unilamellar vesicle; POC,
olk N-acyl-D-sphingosine-1-
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l rights reserved.sphingomyelin (SM). In a couple of cases binding of toxin occurs prefer-
entially to SM and is further increased by availability of cholesterol
[3–5].
The toxin Hla from Staphylococcus aureus also requires POC-carrying
lipids for interactionwith liposomes [6]. This toxin belongs to the class of
β-barrel forming toxins, which share a strong structural similarity with
β-barrel membrane proteins such as outer-membrane proteins or
porins [7]. The high resolution structure of the heptameric pore of Hla,
obtained in presence of detergents, reveals a putative binding site for a
phosphocholine-headgroup [8,9]. One can assume that this binding
site also plays a role for the interaction of Hla monomers with mem-
branes, but detailed information about this process is lacking. Also, the
intermediate oligomeric states have not been characterised yet. Despite
numerous studies the large range of susceptibilities of cells even of the
same type [10] is not understood. Different proteins have been sug-
gested to be involved in Hla binding: band-3 [11], caveolin-1 [12] and
ADAM10 [13]. However, high afﬁnity binding of Hla directly to these
proteins could not be proven so far. Based on the role of SM and choles-
terol for the interaction of Hla with highly susceptible rabbit erythro-
cytes and with artiﬁcial membranes, an alternative type of high afﬁnity
binding site was proposed: clustering of low afﬁnity binding sites
(POC) due to formation of domains enriched in sphingomyelin and cho-
lesterol was suggested to effectively increase the surface density of mo-
nomeric Hla and thus reduce the concentration of toxin required to yield
oligomers and pores [14].
The aim of our study was to investigate to which extent domains
enriched in sphingomyelin and cholesterol increase Hla binding and
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ment. To this end the interaction of Hla with liposomes of different
compositions was monitored based on pyrene-excimer ﬂuorescence
of Hla. To address the inﬂuence of local density of binding sites the lipo-
somes contained Hla-binding lipids were mixed with non-binding
lipids in different relative amounts. In order to test for lipid speciﬁcity
of Hla-binding, the interaction with sphingomyelin and phosphatidyl-
choline was compared. The inﬂuence of lipid phase was investigated
by using both saturated and unsaturated species of sphingomyelin
andphosphatidylcholine. Toqualitatively interpret the results an approx-
imate model describing binding of monomers and formation of dimers
on the membrane was developed. The results show clearly that the sur-
face density of binding sites modulates the efﬁciency of oligomerisation
but that the extent of Hla binding primarily depends on lipid identity
(sphingomyelin or phosphatidylcholine) and lipid phase.
2. Materials and methods
2.1. Chemicals
Egg yolk 1,2-diacyl-sn-glycero-3-phosphocholine (ePC), egg yolk
1,2-diacyl-sn-glycero-3-phosphoethanolamine (ePE), egg yolk N-acyl-
D-sphingosine-1-phosphocholine (eSM), 1,2 diacyl-sn-glycero-3-
phospho-L-serine from bovine brain (bPS), 1,2-dipalmitoyl-sn-glycero-
3-phosphocholine (DPPC) and cholesterol were obtained from Sigma
(Deisenhofen, Germany). N-(9Z-octadecenoyl)-sphing-4-enine-1-
phosphocholine (OSM), 1,2-Distearoyl-sn-Glycero-3-Phosphocholine
(DSPC) and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine
rhodamine B sulfonyl) (Lissamine rhodamine DOPE) were purchased
from Avanti Polar Lipids (Alabaster, Alabama, USA). Chemicals for the
buffer solution and SDS PAGE were from Roth GmbH (Karlsruhe,
Germany). All experiments were performed in phosphate buffer
(70 mM sodium phosphate, pH 7.2).
2.2. Toxin labelling
For ﬂuorescence dye labelling the Hla mutant S3C was used, where
serine on the third position of the amino acid sequence is replaced by
cysteine. This fully active mutant S3C was produced and labelled with
N-3′-pyrenyl-maleimide (PM, Molecular Probes, Eugene, OR) as
described elsewhere [15]. Toxin was kept at −80 °C, slowly thawed
on ice and used directly. Concentration of the eluted protein was
determined based on a variable extinction coefﬁcient taking into
account incomplete labelling (c = (A280 − 0.73A340)/εl with ε the
molar extinction coefﬁcient for unlabelled toxin (ε = 65 000 M−1
cm−1 as determined from the amino acid sequence) and l the optical
pathlength). The absorbance spectrum of pyrene-maleimide conju-
gated with protein was determined from a spectrum of the PM-
mercaptoethanol-adduct. From this we calculated that pyrene-
maleimide conjugated with protein exhibits at 280 nm an absorbance
which is 0.73× the value observed at 340 nm.
2.3. Vesicle preparation
Extruded vesicles (100 nm ﬁlter, extruder from Avanti Polar Lipids,
Alabaster, Alabama, USA) with different relative amounts (expressed
asmol %) of ePE, bPS, PC, SMand cholesterolwere prepared in phosphate
buffer essentially as described elsewhere [14]. Mixtures containing cho-
lesterol plus one type of lipid are denoted binary mixtures, those
containing bPS, ePE, cholesterol and ePC or OSM are referred to as
pseudo-binary mixtures, and those containing bPS, ePE, cholesterol and
DPPC, DSPC or eSM pseudo-ternary. These LUVs were used for all exper-
iments except for ﬂuorescence microscopy. Size and monodispersity of
the LUV suspensionwas routinely checkedwith dynamic light scattering
(Zetasizer Nano ZS, Malvern Instruments GmbH, Herrenberg, Germany)
and found to vary only slightly with preparation. The actual lipidconcentration was determined via the cholesterol content employing
the CHOD PAP assay (Roche diagnostics GmbH, Mannheim, Germany).
Based on the amount of cholesterol in the suspension the concentration
of lipids was calculated. Thin layer chromatography had proven that the
actual lipid composition of this type of liposomes agrees with the
intended one [16], allowing calculation of the lipid concentration based
on this strategy. For efﬂux measurements liposomes were prepared
in 70 mM phosphate-buffer, pH 7.2 containing additionally the self-
quenching dye carboxyﬂuorescein (Fluka, Sigma Aldrich, Germany) in
a concentration of 50 mM. The dye outside the liposomes was removed
employing desalting columns (PD10, Amersham Biosciences Europe
GmbH, Freiburg, Germany).2.4. Fluorescence measurements
Spectra were obtained in micro-quartz cuvettes (volume 400 μl,
Hellma GmbH & Co, Müllheim, Germany) at an excitation wavelength
of 335 nm and emission wavelengths between 350 and 600 nm at the
temperature indicated. Fluorescence spectra were measured with a
Hitachi F4500 (Binninger Analytic, Schwaebisch Gmuend, Germany)
or a Fluorolog II (Horiba Scientiﬁc, Unterhaching, Germany). Spectra
of liposomes without toxin were subtracted before data evaluation.
The liposomes were incubated at the Hla and lipid concentration as in-
dicated, but diluted to 0.1 μM directly before the measurement if incu-
bation concentrations of Hlawere higher than 0.1 μM. In a few cases the
samples weremeasured without dilution (Fig. 3b) and the results were
basically the same, indicating that no signiﬁcant dissociation occurs.
Furthermore, the sum of dissociation rate of monomers and oligomers
was estimated to be b0.01 s−1, corresponding to a half-life of the olig-
omers of >100 s (see Results). Thus, the ﬂuorescence signal as mea-
sured under these conditions represents the situation characteristic
for the incubation concentrations. Fluorescence data were always mea-
sured at 20 °C, irrespective of incubation temperature in order to allow
comparison of ﬂuorescence intensity. Concentration of Hla-binding
lipids (PC and SM) is given in terms of the fraction available for
Hla-binding, e.g. only those on the outer leaﬂet of the liposomes.
In cases, where the results of several experiments were plotted to-
gether, the amount of excimers formed was quantiﬁed by calculation
of the excimer peak area (430 to 600 nm) relative to the total area,
indicated as Frelolig. Otherwise, the ﬂuorescence of the excimer peak
was plotted directly, indicated by F475.
The amount of SDS-stable oligomers was compared between differ-
ent experimental conditions by measuring the excimer ﬂuorescence
after addition of 100 μl of a 10% SDS solution to 400 μl solution
containing Hla and liposomes. Fluorescence of monomeric Hla in ab-
sence of lipids typically increases by a factor 1.4–1.5 upon addition of
SDS. However, the excimer ﬂuorescence is much less affected by pres-
ence of detergents than monomer ﬂuorescence [17]. Thus, the relative
residual excimer ﬂuorescence is expected to be reduced even if none
of the oligomers dissociate due to the detergent, but the exact ratio is
not known. However, the signal serves only for comparison among
the different lipid mixtures. Alternatively, SDS stable oligomers were
detected employing SDS–PAGE [18], but omitting heating of the sample.
Gels were stained according to [19].2.5. Stopped ﬂow experiments
Fast reactionswere followedwith a SF 61DX2 (TgK Scientiﬁc Limited,
Bradford upon Avon, UK) stopped-ﬂow apparatus with a high band-
ﬁlter (cut-off 455 nm) in the ﬂuorescence channel at an excitation
wavelength of 335 nm. Toxin and Hla-binding lipid concentrations
refer to the concentration in the cell after mixing. Concentrations of
Hla-binding lipid reﬂect only the fraction of the lipids present in the
outer leaﬂet.
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GUVs were produced in water following an electroformation proto-
col on ITO slides (Sigma Aldrich, Germany) with details as described
earlier [16]. Phase separation was monitored employing the ﬂuores-
cently labelled lipid Lissamine rhodamine-DOPE (0.1 mol %, Avant
Polar Lipids, Alabaster, Alabama, USA) which preferentially partitions
into the liquid disordered phase. Fluorescence micrographs were
taken with a Keyence BZ-8000 ﬂuorescence microscope (Keyence,
Neu-Isenburg, Germany; Filtersets: λex = 560/40; λem = 630/60).
3. Results
Oligomerisation of Hla on liposomes (LUVs) of different composi-
tions was followed employing the formation of excimer ﬂuorescenceFig. 1. Kinetics of excimer formation for different concentrations of Hla and eSM. Lipo-
somes containing 40% eSM, 40% cholesterol, 10% ePE and 10% bPS were rapidly mixed
with ﬂuorescently labelled toxin at 20 °C. Excimer ﬂuorescence after subtraction of the
initial value (Fo) is depicted. The grey symbols represent the data, the black lines a ﬁt
based on a mono exponential function (F = a + b(1 − exp(−kobs*t))). Panel A depicts
data obtained at ﬁxed toxin concentration (0.3 μM) and variable concentration of eSM
(number given refer to the concentration of eSM in the outer membrane [eSMol]). Panel
B depicts data obtained at ﬁxed concentration of eSM ([eSMol] = 17 μM) and variable
toxin concentration. In panel C the kinetic constants (kobs) are summarized. Error bars
are as estimated by the ﬁtting procedure.of pyrene-labelled Hla. The aim was to dissect the contributions of
type of Hla binding lipid, its surface density and its phase with respect
to efﬁciency of Hla binding and oligomerisation.3.1. Binding of monomers is fast and weak
The kinetics of excimer-formation determined in stopped-ﬂow ex-
periments could be well ﬁtted with 1, 2 or 3 exponential functions,
depending on the time range and the extent of oligomerisation
(Fig. 1). This indicates that no lag-phase occurs since this requires dif-
ferent types of functions to describe the data. Thus, oligomerisation
starts immediately after mixing, implying that monomer binding oc-
curswithin the dead-time of the instrument (about 3ms). If monomer
binding was slow compared to oligomer formation, a lag-phase in the
excimer-signal would result since this represents the time required to
accumulate enough membrane bound monomers for measurable
amounts of oligomers. Since such a lag-phase was not detected in
any of the stopped-ﬂow experiments (Figs. 1, 4, and 7), at the toxin
concentration employed in these experiments (≥0.3 μM) the process
of monomer binding is close to equilibrium prior to oligomerisation.
For liposomes containing 40% cholesterol, 40% eSM, 10% ePE and 10%
bPS kinetics was followed at different eSM and toxin concentrations
(Fig. 1a,b). The largest rate constant, denoted by kobs, reﬂects the ini-
tial phase and increases with lipid and toxin concentration (Fig. 1c).
While an increase with toxin concentration is certainly expected the
reason for the observed dependence on lipid-concentration is less
clear. Thus, in order to qualitatively describe the oligomerisation be-
haviour of Hla on a membrane, we developed a model for monomerFig. 2. Concentration dependence of oligomer formation. Liposomes containing 40% cho-
lesterol, 10% bPS, 10% ePE and either 40% ePC (open triangles) or 40% eSM (closed circles)
were incubatedwith pyrene labelled toxin for 24 h at 4 °C. Panel A: Data obtained at con-
stant toxin concentration (4 μM) and variable concentration of binding sites (concentra-
tion of eSM or ePC on the outer leaﬂet, respectively). The black curves represent a ﬁt
based on a hypberbolic function (see Eq. (A7)) with c50 = 10 ± 2 μM, Fo = 23 ± 1
(eSM) and c50 = 15 ± 5 μM, Fo = 9 ± 1 (ePC). Panel B depicts data obtained at constant
concentration of Hla-binding lipids: [eSMOL] = [ePCOL] = 2.5 μM. The lines represent
a ﬁt based on the Hill-equation (Eq. (A8)) with c50 = 210 ± 30 nM (eSM) and c50 =
480 ± 60 nM (ePC). The ﬁt is only used to estimate c50 (see text for details).
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alytical solutions for the time-dependent and equilibrium concentra-
tion of dimers can be obtained. Whenever this model is used for
discussing the results, we refer to “dimer” and “dimerisation con-
stant”, in order to distinguish the model from the experimental data,
which certainly include also higher oligomers.
Comparison of the trends in kobs as experimentally observed with
the equation describing kobs in a dimer-model (Eq. (A6)), reveals that
the results of the kinetic experiments are in accordance with a situation
where oligomerisation occurs from a pool of bound monomers which
are in rapid equilibrium with free monomers (see Appendix A,
Eq. (A6)). The dependence on eSM-concentration is weaker than the
dependence on the toxin concentration, as can also be rationalised by
inspecting Eq. (A6). Based on these experiments we can estimate that
the sum of dissociation-rate for oligomers and monomers is smaller
than about 0.01 s−1, corresponding to a half-life of about >100 s.
In order to obtain information about the level of oligomers under
equilibrium conditions, pyrene excimer formation was also deter-
mined after prolonged incubation (24 h, 4 °C) for different toxin and
Hla-binding lipid concentrations (Fig. 2). Here, a low temperatureFig. 3. Enhancement of oligomerisation by surface density. Liposomes containing different f
40 s or 45 min, at 22 °C or 37 °C. For estimation of the SDS stable oligomers, which includ
Concentration of Hla binding lipids was kept constant at 17 μM (corresponding to the lipid m
ﬂuorescence obtained at 37 °C is depicted by bars (black: eSM; grey: ePC), results obtained a
level of pyrene ﬂuorescence measured in absence of liposomes. Samples were incubated at 4
rescence was measured after 45 min incubation time at 22 °C (symbols) or 37 °C (bars) for
maximal loading capacity seems to be reached. In case of ePC this level requires a higher toxi
given, and also measured at this concentration.(4 °C) was chosen for two reasons: ﬁrst, due to the slow rate of oligo-
mer formation at low toxin concentrations, long incubation times
were needed to obtain a measurable amount of excimer ﬂuorescence.
Unfortunately, at elevated temperatures the toxin is not stable at ex-
tended incubation times. However, the oligomerisation process itself
is only weakly temperature dependent (see below); thus the results
obtained at low temperature are representative for the general
oligomerisation behaviour. Secondly, at low temperatures the transi-
tion to the lytic pore is strongly suppressed; thus the excimer signal
stems mainly from non-pore oligomers on which we would like to
focus here (see also Fig. 7).
The curve obtained at low toxin concentration (100 nM) and dif-
ferent Hla-binding lipid concentrations (Fig. 2a) showed that about
10–15 μM Hla-binding lipid is required to achieve half-maximal olig-
omer formation. The curves can be well described by a hyperbolic
curve (Eq. (A7)) with a c50 value of 10 ± 2 μM for eSM and c50 =
15 ± 5 μM for ePC. However, since excimer ﬂuorescence requires
formation of at least a dimer the c50 does not correspond to themono-
mer binding constant Kb, but reﬂects a combination of Kb and the
equilibrium constants describing the oligomerisation process. Theractions of Hla-binding lipid (eSM or ePC) were incubated with pyrene labelled Hla for
es the pores, excimer ﬂuorescence (at 475 nm) was measured in presence of 2% SDS.
olecules in the outer leaﬂet) by appropriate dilution of the liposomes. Panel A: Excimer
t 22 °C are depicted as symbols (circles: eSM; triangles: ePC).The grey line indicates the
μMHla and diluted to 0.1 μM directly before the measurement. Panel B: Excimer ﬂuo-
different concentrations of Hla. Note that for liposomes containing 40% eSM or ePC the
n concentration than in case of eSM. Samples were incubated at the toxin concentration
Fig. 4. Dependence of oligomerisation kinetics on surface density of binding sites. Lipo-
somes containing 40% cholesterol and variable fractions of Hla binding lipids (17 μM in
the outer leaﬂet) were rapidly mixed with ﬂuorescently labelled toxin (0.3 μM) at
20 °C. The relative amount of Hla-binding lipids is indicated, non-binding lipids (ePE
and bPS, 1:1) are used to ﬁll up to 100%. Panel A: eSM (black lines) and ePC (grey
lines), relative amounts as indicated. Panel B: 10% eSM and 10% ePC (black lines),
10% DPPC and DSPC (grey lines).
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high lipid concentrations bound monomers should be sufﬁciently
diluted on the liposome surface to reduce visibly the formation of di-
mers. Based on simulations we can show that the occurrence of a
hyperbolic curve in this lipid-concentration range is a clear indication
for a low monomer binding afﬁnity. Our simulation was again based
on the simpliﬁed model of dimer formation, and demonstrates for
which combinations of Kd and Kdim such a hyperbolic binding curve
can be expected (Fig. A1a,b). A hyperbolic shape is observed at a
value for Kb of 0.01 μM−1 for a range of dimerisation constants
(100–5000 nm2, Fig. A1a). In contrast, already at Kb = 0.1 μM−1 a de-
crease in dimers at higher lipid concentration is predicted (Fig. 1Ab).
Thus, we can deduce that for both lipids (eSM and ePC) monomer
binding is rather weak. Compared to eSM the K50 for ePC is slightly
shifted and the maximal level of oligomeric species is visibly de-
creased. In frame of a dimer model, this combination indicates that
the dimerisation constant is lower in case of ePC but the Kb is similar
(see Appendix A, Fig. A1c and d).
Variation of toxin concentration at ﬁxed concentration of binding
sites (2.5 μM eSM and ePC, respectively, Fig. 2b) supports the ﬁndings
above: in case of ePC a clear sigmoid shape of the saturation curve is
observed, whereas in case of eSM the curve seems to be nearly hyper-
bolic since the sigmoid part is shifted towards lower concentrations
of toxin. The concentration of total toxin needed to achieve half satu-
ration is about 210 nM for eSM and 480 nM for ePC as determined by
ﬁtting a Hill-equation (Eq. (A8)) to the data. These values reﬂect the
concentration of toxin necessary to obtain half maximal occupation
of the liposomes. Based on purely geometric considerations (see
Appendix A) the surface of the liposomes could carry maximally
about 240 nM toxin at the lipid concentration employed. Thus, if at
210 nM total toxin concentration 50% of these “binding sites” are oc-
cupied, the apparent Kd value is 210 − 120 = 90 nM. In case of ePC a
value of 480 − 120 = 360 nM is obtained. These Kd values reﬂect
the average of dissociation constants of the different oligomerisation
states present at 50% occupation. The comparison of the results
based on Fig. 2a and b clearly demonstrates that the average afﬁnity
for binding is increased by at least a factor of 100 upon formation of
oligomers.
3.2. Modulation of oligomerisation by surface density of binding sites
The oligomerisation level should increase if the same number of
bound monomers is distributed over a smaller number of liposomes.
Thus we compared the interaction of Hla with liposomes under con-
ditions where all parameters are constant except the average distance
of bound monomers on the liposome surface. This was achieved by
changing the fraction of Hla receptor lipids (corresponding to the pa-
rameter α in Eq. (A4)). Thus, either ePC or eSMwas mixed with lipids
which do not bind to Hla (ePE, bPS) and cholesterol (40%) at various
fractions. In each case the concentration of binding sites for the toxin
(ePC or eSM) was kept constant.
If ePC, which is in the liquid disordered phase at the experimental
temperature, was mixed with ePE, bPS and cholesterol, a signiﬁcant
oligomer formation was only obtained at a high fraction of ePC
(Fig. 3a), indicating that a certain surface density is required for effec-
tive monomer-monomer interaction. If ePC is substituted by eSM,
which has a phase transition temperature (Ttrans = 41 °C) well
above the experimental temperature (22 °C and 37 °C), a higher con-
centration of oligomerswas found at the same average surface density
of Hla-binding lipid except at the highest fraction of ePC and eSM, re-
spectively, where the level is similar. For example in order to achieve
the level of oligomer formation obtained with liposomes containing
3% eSM after 45 min, a 7-times higher fraction (20%) is required in
case of ePC. The drop of excimer ﬂuorescence at higher eSM fractions
in comparison to 10% eSM can be attributed to limitations of the total
liposome surface at the concentration employed in this study, since ahigher fraction of Hla-binding lipids implies a lower number of lipo-
somes in order to keep the concentration of lipids constant. If a
lower concentration of toxin is employed (b1 μM) the excimer ﬂuo-
rescence intensity at 10% eSM is typically lower than at 40% eSM
(Fig. 3b). In agreement with the experimental results geometric con-
siderations (see Appendix A) also indicate, that only about 1.6 μM
toxin can be accommodated by the liposomes containing 40% ePC or
eSM at the given lipid concentration. The differences observed be-
tween ePC and eSM were similar for two temperatures (22 °C and
37 °C), two incubation times (about 40 s and 45 min) and also for
two types of species: all oligomeric forms (before addition of SDS)
and SDS stable oligomers (after addition of SDS). After addition of
SDS, only SDS-stable oligomers, which include the pores, exhibit
pyrene-excimer ﬂuorescence, and thus as expected the level of
excimer ﬂuorescence is higher at an incubation temperature of 37 °C
compared to 22 °C, unlike the pyrene-excimer ﬂuorescence before ad-
dition of SDS, which is very similar at both temperatures.
The kinetics of oligomer formation (Fig. 4) support the results
shown above: the speed of oligomer formation is signiﬁcantly reduced
with ePC as Hla binding lipid compared to eSM. Here, even at 40% ePC
and eSM, respectively, a signiﬁcant difference was observed. This can
be ascribed to the lower toxin concentration employed (0.3 μM in
Fig. 4 compared to 4 μM during incubation in Fig. 3a) and also one can
expect that the differences are more pronounced at short reaction
times. For 10% ePC only a very low level of oligomers forms in the ﬁrst
300 s. For eSM the kinetics of excimer formation could be measured
for 5%, 7%, 10% and 40% eSM. The apparent initial rate constants increase
with increasing fraction of eSM (from kobs = 0.0025 s−1 to 0.007 s−1
over 0.0251 s−1 and 0.030 s−1). Thus as expected based on Eq. (A6) a
positive correlation between α and kobs is observed.
3.3. Role of Hla-binding lipid type and lipid phase
In the experiments described above, two different lipids (PC and SM)
were compared which are in two different regimes with respect to their
phase transition temperature Ttrans relative to the experimental temper-
ature Texp (SM: Texp b Ttrans, PC: Texp > Ttrans). Thus, in order to
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ly compared the interaction of Hla with PC-species where Texp b Ttrans
(DPPC, DSPC) and a SM species, where Texp > Ttrans (OSM) at different
relative amounts of Hla receptor lipid. Upon replacing ePC by DSPC or
DPPC practically no oligomer formation was observed within the ﬁrst
100 s (Fig. 4b) and also at later time points (2 h, 9 h) the level was
well below the one observed for ePC (data not shown). In contrast, if
conversely eSM is replaced by OSM the extent of oligomer formation re-
mains on the same level in the pseudo-ternary/pseudo-binary mixtures
but is higher for OSM in case of binarymixtures (Fig. 5a). The latter ﬁnd-
ing suggests that a liquid ordered phase as present in the binarymixture
of eSM and cholesterol is less favourable for oligomerisation than a liq-
uid disordered phase as present in case of OSM. The pattern observed
with respect to the total extent of oligomer formation as represented
by excimer ﬂuorescence is reproduced if the amount of SDS stable olig-
omers is addressed by SDS–PAGE. The results for the whole set corre-
sponding to Fig. 5a are shown in Fig. 5c, together with the gel from
one subset of data (Fig. 5b). Except in the binary mixtures, the fraction
of SDS stable oligomers for liposomes containing eSM or OSM is very
similar. Unlike pyrene-excimer formation, the temperature dependence
of the formation of SDS stable oligomers is very pronounced, as was also
seen in Fig. 3a. Interestingly, a binarymixture of OSMwith cholesterol isFig. 5. Role of ﬂuidity for Hla–SM interaction. Liposomes containing 40% cholesterol and varia
for 40 s or 45 min at 20 °C or 37 °C with 4 μM pyrene labelled Hla. The rest of the lipid cons
for pseudo-ternary and pseudo-binary mixtures (10, 20 and 40% SM with 40% cholesterol an
Samples were diluted to 0.1 μM directly before measurement. Bars indicated liposomes
containing OSM as Hla-binding lipid. For comparison, ﬂuorescence levels measured in ab
were subjected to 10% SDS–PAGE without heating. A gel showing part of the samples (45
based on a densitometric analysis (Quantity One, Bio-Rad, München, Germany). The resu
eSM and symbols indicating liposomes containing OSM. Incubation time and temperature w
München, Germany).less efﬁcient in inducing excimer formation than pseudo-binary mix-
tures containing additionally ePE and bPS, especially with respect to for-
mation of SDS-stable oligomers.
3.4. Phase separation behaviour of pseudo-ternary mixtures
In case of phase separation the local density of binding sites will
deviate from their average density. To check the mixtures employed
in our binding studies for domain formation GUVs composed of choles-
terol, ePS, ePE and ePC, eSM, DPPC or OSM were produced with 0.1%
Lissamin-Rhodamin-DOPE as ﬂuorescent lipid (Fig. 6). This lipid usually
partitions preferentially into the liquid-disordered phase [20]. Despite
the rather high cholesterol content phase separation was observed in
these mixtures if high TM-lipids were used (DPPC, eSM) whereas for
low-Tm-lipids (ePC, OSM) no phase separation seems to occur. In case
of ePC it was shown that also in LUVs no phase separation occurs [21].
3.5. Temperature dependence of oligomer formation
The weak dependence of oligomer formation on temperature as re-
vealed in Fig. 3a was supported by kinetic experiments (Fig. 7). The ini-
tial reaction rates show an increase with temperature (0.028 s−1,ble fractions of two types of sphingomyelin (17 μM in the outer leaﬂet) were incubated
ists of ePE and bPS in a ratio of 1: 1. Panel A: Relative excimer ﬂuorescence as obtained
d 1: 1 ePE/bPS) and binary mixtures (60% SM with 40% cholesterol, indicated by a star).
containing eSM, symbols (squares, triangles, circles, diamond) represent liposomes
sence of liposomes (“toxin”) are depicted. After incubation, aliquots of the samples
min, 37 °C) is depicted in panel B; the numbers represent the fraction of oligomers
lts for all samples are depicted in panel C, with bars indicating liposomes containing
as as given in the legend. Marker: Precision Plus Protein unstained Standards (Bio-Rad,
Fig. 6. Fluorescence microscopy of GUVs with pseudo-binary and pseudo-ternary mix-
tures. GUVs containing 40% cholesterol, fraction of Hla binding lipid as indicated and 1:
1 ePE/bPS were analysed with respect to phase separation properties. GUVs with ePC
and OSM show no phase separation, whereas GUVs with DPPC and eSM show phase sep-
aration. The bright regions indicate areas in the ﬂuid disordered phase due to preferential
partitioning of Lissamine rhodamine-DOPE (0.1 mol %) therein. Scale bars indicate 5 μM.
1968 M. Schwiering et al. / Biochimica et Biophysica Acta 1828 (2013) 1962–19720.037 s−1 and 0.108 s−1) but the overall oligomerisation level is simi-
lar for 4 °C, 22 °C and 37 °C. In contrast, efﬂux of encapsulated dye is
strongly temperature dependent with barely any efﬂux at 4 °C and a
signiﬁcant difference between 22 °C and 37 °C (Fig. 7). Since pores are
SDS stable, this corresponds to the pronounced difference between
20 °C and 37 °C in the level of SDS-stable oligomers (Fig. 3a).
4. Discussion
It is well established that binding of Hla from S. aureus to lipid
membranes occurs only in presence of lipids with a phosphocholine
headgroup, namely SM or PC, at least at neutral and basic pH [6,22].
Most studies have been performed either with vesicles composed
of one type of lipid or with binary mixtures of cholesterol and lipid.Fig. 7. Temperature dependence of kinetics of Hla–liposome interaction. Liposomes
containing 40% cholesterol, 40% eSM, 10% ePE and 10% bPS (17 μM eSM in the outer
leaﬂet) were rapidly mixed with ﬂuorescently labelled toxin (0.3 μM) at 4 °C, 20 °C
and 37 °C to follow oligomer formation (grey lines). The kinetics of pore formation
was followed based on efﬂux of a self-quenching dye at the same temperatures. One
hundred percent efﬂux was determined by addition of 10% Triton-X100. Solid line:
4 °C; dashed line: 22 °C; dotted-dashed line: 37 °C. Fluorescence is corrected for
pure temperature effects.Preferential binding of Hla to SM or PC was not reported for these
liposomes. More recent experiments employing pseudo-ternary mix-
tures seemed to indicate that clustering of phosphocholine carrying
lipids reduces effectively the concentration of toxin necessary to
obtain measurable amounts of bound toxin [14]. In case of Hla the
oligomerisation efﬁciency was considered to be a crucial parameter
for determining the susceptibility of cells since based on competition
experiments [6,14] it was concluded that the interaction between
phosphocholine and Hla monomer is weak and clear indications for
a high-afﬁnity interaction with proteins on the cellular membrane
are not reported. By investigating the oligomerisation behaviour of
Hla under controlled conditions and model based interpretation of
the results we were able to characterise the Hla–lipid interaction in
more detail.
In support of the inhibition studies, our study clearly shows that
the initial contact of monomeric Hla with lipids in artiﬁcial mem-
branes occurs with low afﬁnity, with dissociation constants in the
higher μM range. In consequence measurable binding occurs only if
oligomerisation takes place, thus the distinction between monomer
afﬁnity and oligomer afﬁnity is difﬁcult. Another consequence of the
low afﬁnity is that the amount of bound toxin increases with increas-
ing concentration of Hla-binding lipids (see Appendix A). Thus, for a
meaningful comparison of the effects of surface density it is crucial
to adjust liposome concentration to yield the same molar concentra-
tion of Hla-binding sites. In our study this was taken into account for
the ﬁrst time. Thus, our results unambiguously show that increased
oligomerisation can be induced by increasing the surface density of
Hla binding lipids. According to Eqs. (A4) and (A6) increasing the sur-
face density of binding sites (α) has the same effect as an increase in
the dimerisation constant (Kdim), since both parameters occur always
as product. Thus the increase in oligomerisation as shown in Fig. 3A
can be attributed to the increase in surface density assuming that
the oligomerisation constant is the same for the same type of lipid
at different compositions. This might not be exactly the case: some
effect of membrane composition on the oligomerisation constant
can be deduced from the somewhat reduced oligomerisation level
found with binary mixtures compared to pseudo-binary mixtures in
case of OSM (Fig. 5a).
Obviously, oligomerisation efﬁciency is higher in case of eSM
containing liposomes than in those where ePC is the Hla-binding
lipid. One possible reason is that in case of eSM phase separation oc-
curs and thus locally the surface density of Hla binding lipids is in-
creased. Indeed in mixtures containing ePC no phase separation was
observed, while the mixture containing eSM formed domains. Thus,
the increased oligomerisation level in case of eSM could be the conse-
quence of phase separation. However, since replacement of eSM by
OSM, which did not lead to phase separation, did not change signiﬁ-
cantly the oligomerisation level compared to eSM, we have to con-
clude that SM per se leads to higher levels of oligomers compared to
PC. The observation that pseudo-binary mixtures containing OSM
leads to similar oligomer levels as pseudo-ternary containing eSM
indicates two counteracting tendencies: phase separation increases
local surface density, thus increasing oligomerisation level, but for-
mation of a liquid ordered phase reduces oligomer formation. The re-
ducing effect of formation of a liquid ordered phase is very evident in
the comparison of binary mixtures of eSM and OSM, respectively,
with cholesterol. In case of PC as Hla-binding lipid this effect is even
more pronounced: replacing ePC by DPPC increases the local surface
density of binding sites as evidence by ﬂuorescence microscopy but
the oligomerisation level of Hla decreases: obviously the membrane
properties in DPPC-enriched domains do not support oligomerisation.
This agrees with studies with binary mixtures of PC and cholesterol
below and above the transition temperature, where in case of liquid
ordered phase the level of bound toxin was very low [23]. Overall
these data clearly show that under similar conditions (ePC versus
OSM, DPPC versus eSM) oligomerisation on membranes containing
1969M. Schwiering et al. / Biochimica et Biophysica Acta 1828 (2013) 1962–1972SM occurs with signiﬁcantly increased efﬁciency. Phase separation as
process which increases local surface density might increase the efﬁ-
ciency to some extent, but is partially compensated by unfavourable
conditions introduced by the transition to a liquid ordered phase.
The picture emerging from this study is that Hla similar to a num-
ber of other POC-dependent toxins [3–5] has some speciﬁcity for SM
which was not detected up to now. Due to the rather low intrinsic
afﬁnity with respect to the initial monomer binding the apparent
binding is strongly inﬂuenced by the efﬁciency of oligomer forma-
tion. Thus, the apparent binding constant (c50) depends both on
monomer binding afﬁnity and oligomerisation constant. So far our
model based data analysis indicates that preferential interaction of
Hla to SM compared to PC results from a higher probability of
oligomerisation rather than a higher afﬁnity for monomer binding.
Since a signiﬁcant population of membrane bound toxin is only ob-
served if oligomers are formed and bound monomers exist only in
minor amounts, direct determination of the afﬁnity for monomer
binding is difﬁcult.
Initial interaction of Hla with lipid membranes seems to occur via
the POC-binding site as identiﬁed in the crystal structure of the
heptameric pore and in the structure of the monomeric form of the
closely related toxin LukF [8,9,24]. Since only the headgroup is
recognised by this site it is unlikely that this interaction is the reason
for speciﬁc binding to SM or PC, and this agrees with our result that
monomer binding afﬁnity for the two lipids might be similar in case
of Hla. Thus, additional interactions between bound monomer and
membrane must occur, possibly leading to different orientations of
the bound monomer for the two types of lipids, which could explain
different probabilities of oligomerisation.
In this study we could not distinguish between different oligomer-
ic states on the membrane. However, the observation that no
lag-phase in the kinetic traces was observed indicates that at least
in this initial phase dimers, trimers etc. exist. Under equilibrium con-
ditions possibly mainly heptameric oligomers exist: recent experi-
ments indicated that the main membrane bound species after
30 min incubation are heptamers and that smaller oligomers are
only weakly populated [25].
With respect to the initial lipid binding partner on the cell mem-
brane or lipid “receptor” one has to conclude that due to the high
relative content of unsaturated PC and saturated SM in the plasma
membrane the surface density of binding sites is not likely to play a
role for selective binding. Both in rabbit and human erythrocytes PC
and SM together contribute more than 85% of the outer leaﬂet-lipids
[26,27], with cholesterol contributing 0.8 mol/mol lipid in rabbits
[26] and in humans [28]. Thus the surface density of the two lipids is
not likely to differ very much and is well represented by the composi-
tions containing 40% eSM and 40% ePC. Nevertheless, a preferential
binding of Hla to SM in the cellular context can be expected due to
an intrinsically higher overall afﬁnity as evidenced by our liposome
studies. Thus, removal of SM is expected to reduce cytotoxicity of
Hla as has been observed [14]. However, a particular role for rafts can-
not be deduced from this observation.
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Appendix A. Dimerisation model
In order to be able to interpret the results on oligomer formation as
monitored by excimer-ﬂuorescence in more detail, we developed a
model describing equilibrium concentration and kinetics of dimer for-
mation. Ideally one would use a model describing all steps up to theﬁnal heptamer, but the large number of parameters deﬁning such a
model prevents this, since the values for these parameters are not
known yet. However, since the aim of using this model is solely to un-
derstand the quantitative behaviour of such an oligomerisation process
upon variation of Hla concentration, lipid-concentration etc., we used
the minimal oligomer model (dimer model) which has the additional
advantage, that the solution for kinetics and equilibrium are analytic
and compact enough to allow an intuitive understanding. Otherwise
an intensive screening of possible parameter combinations would be
necessary, which is beyond the scope of this article. The set-up of the
model is the same as used by [29].
Thus, we consider the following reaction scheme:
}
Binding of soluble monomers (csol) to lipid membranes occurs to
speciﬁc toxin-binding lipids, denoted receptor lipids (crep). Bound
monomers (c1) can dimerize on the membrane. Dimers (c2) can disso-
ciate to bound monomers, or leave the membrane as dimer. In solution
they rapidly dissociate into soluble monomers; thus the rate limiting
step in this path is dissociation from the membrane (koff). The
dimerisation equilibrium constant is given by Kdim = kdim+/kdim−,
the monomer binding constant by Kb = kb+/kb−.
Equilibrium model for dimerisation on the membrane
Surface densities (σx) of species x (x = 1 (monomer), 2 (dimer),
tot (total toxin) or rep (receptor-lipid)) are expressed as number
per nm2 of membrane surface available where only the area of the
outer leaﬂet is taken into account:
σ x ¼
cx
Avescves
¼ q
Alip
cx
clip
¼ r cx
clip
Cves ¼ clip=N
N ¼ qAves=Alip
with Aves = area of the outer leaﬂet of the vesicle, q = (area of
inner + outer leaﬂet)/(area of the outer leaﬂet), q ≈ 1.8 for øliposome
= 100 nm, N = number of lipids per liposome, clip = concentration
of lipids (mol/l) and Alip the area per lipid. With typical values for
Alip (0.6 nm2) one obtains at value of r ≈ 3 nm−2.
The surface concentration of dimers on the membrane is deter-
mined by the corresponding dimerisation constant (Kdim, units: nm2)
and the surface densities of monomers:
σ2 ¼ K dimσ21 ðA1Þ
The concentration of bound monomer is expressed by the re-
spective equilibrium constant Kb, the concentration of toxin in solu-
tion (csol) and the concentration of lipids to which the toxin can
bind (“receptor”) which is only a fraction α of the total lipid
(crep = α clip):
c1 ¼ Kbcrepcsol
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the appropriate binding constant Kapp:
σ1 ¼ Kappσ sol
Kapp ¼ Kbcrep ðA2ÞIn the current situation (Fig. 2a) wemay assume that crep = crep,total
due to the low concentration of toxin relative to receptor lipid. Mass
balance is employed to solve for σ1, yielding:
0 ¼ σ sol þ σ1 þ 2σ2−σ tot ¼ 2K dimσ21 þ
σ1
Θ
−σ tot Θ ¼
Kapp
1þ Kapp
σ1 ¼
1
4ΘK dim
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ 8K dimΘ2σ tot
q
−1
 
ðA3Þ
For a description of the type of data as shown in Fig. 2a we need the
ﬂuorescence signal F, which is proportional to the dimer concentration
c2, in dependence on receptor concentration crep. If the speciﬁc ﬂuores-
cence signal is expressed permonomer and employing c2 = σ2clip/r, we
obtain:
F ¼ Fo2c2 ¼ Fo
1þ Kbcrep
 2
K fitcrep
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ K fit
crep
1þ Kbcrep
 2 co
vuut −1
0
B@
1
CA
2
K fit ¼ 8K dimrαK2b
ðA4Þ
Eq. (A4) shows that the lipid dependence is mainly determined by
the productKdimKb2, especially if crep b 1/Kb. Thus it is difﬁcult to separate
the effect of changes in experimental conditions on the dimerisation
constant from those on the monomer binding constant.
This function has amaximum at crep = 1/Kb. At values of crep > 1/Kb
the level decreases due to surface dilution. However, this decrease is
only observed if Kb is not too low and Kdim not too high. This is depicted
in Fig. A1a and b, were for two values of Kb the binding curves for differ-
ent dimerisation constants are compared. In case of Kb = 0.01 μM−1
typical saturation curves result up to 100 μM lipid (Fig. A1a), whereas
for Kb = 0.1 μM−1 a decrease of dimer level at increased lipid concen-
tration is observed (Fig. A1b). Also for Kb = 0.01 μM−1 a decrease in
saturation level occurs at lipid concentrations >100 μM; only at very
high dimerisation constants this effect is nearly absent. This effect can
be seen also in Fig. A1b: the higher the dimerisation constant the less
pronounced the decrease in dimer level at increased lipid concentration.
The function describing the maximal concentration of dimers at
crep = 1/Kb is given by:
c2;max ¼
1
2
ctot þ
1−
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ 2bctot
p
b
 !
b ¼ rαK dimKb
Thus, the maximal value is constant, if the product of monomer
binding afﬁnity Kb, dimerisation constant Kdim and fraction of receptor
lipids α, which reﬂects the surface density of binding sites, is constant.
The effect of changing Kb and Kdim on the expected dimer level at
100 μM lipid (2c2) and the concentration to achieve half of this level
(c50) is depicted in Fig. A1c and d. The compensating effect of increasing
Kb and simultaneously decreasing Kdim can be veriﬁed in Fig.A1d: the
values for c2 at 100 μM lipid, which is close to the maximal level at
these conditions, is the very similar for Kb = 0.005 μM−1 and Kdim =
5000 nm2 and Kb = 0.01 μM−1 and Kdim = 2500 nm2, respectively.Fig. A1. Simulation of dimerisation behaviour on a membrane. Dimer concentration in
dependence on receptor concentration was simulated based on the model described in
the Appendix for ctot = 0.1 μM, α = 0.6, r = 3, and variable values for Kb and Kdim.
Panel A: monomer binding constant Kb = 0.01 μM−1 and Kdim = 100, 200, 500, 700,
1000, 2000, 5000 nm2, increasing in direction of the arrow; panel B: Kb = 0.1 μM−1;
Kdim as in panel A; panel C: c50 values for the curves in panel A (Kb = 0.01 μM−1,
closed circles) and for Kb = 0.005 μM−1, open triangles. The stars indicate the c50
values found in the experiments for eSM and ePC, respectively. Panel D: levels of
dimer formation (c2) at 100 μM receptor lipid for the same simulation as basis for
panel D. Stars indicate positions with similar relative amount of dimers as found for
the relative intensity of excimer ﬂuorescence in the experiments with liposomes
containing ePC and eSM, respectively (Fig. 2a).
1971M. Schwiering et al. / Biochimica et Biophysica Acta 1828 (2013) 1962–1972Furthermore, we can support based on these ﬁgures, that most
likely the main difference in Hla-interaction with eSM and ePC is
increased oligomerisation efﬁciency in case of eSM. A slight increase
of c50 from 11 to 15 μM (Fig. A1c, stars) and a strong reduction of
dimer level (2c2, Fig. A1d, stars) is compatible with an increase in
monomer binding afﬁnity by a factor of 2 (from Kb = 0.005 to
0.01 μM−1) and a decrease in dimerisation constant by a factor of 25
(from 5000 to 200 nm2). If monomer binding afﬁnity was the same
for both lipids, the c50 should have changed much more in order to
be compatible with a strong decrease in dimer level.
Kinetics of dimerisation
For the dimerisation process we may write
d
dt
σ2 ¼ kdimþσ21− kdim− þ koffð Þσ2 :¼ kdimþσ21−k σ2 ðA5Þ
If monomer binding is much faster than dimerisation, the mono-
mers on the membrane are in a rapid equilibrium with soluble mono-
mers and can be expressed as:
σ1 ¼ σ tot−2σ2ð ÞΘ
Substitution of σ1 into Eq. (A5) yields:
d
dt
σ2 ¼ kdimþΘ2σ2tot−kdimþΘ2σ24 σ tot−σ2ð Þ−k σ2
Since in the initial phase we can approximate σtot − σ2 ≈ σtot
d
dt
σ2;ini ¼ kdimþΘ2σ2tot− kdimþΘ24σ tot þ k
 
σ2
Substituting for molar concentrations yields
d
dt
c2;ini ¼ kdimþ
Kb
Kbcrep þ 1
 !2
creprαc
2
tot− kdimþ
Kb
Kbcrep þ 1
 !2
crep4rαctot þ k
 !
c2
The solution for this differential equation is a simple exponential
function with a time constant of
kobs ¼ 4rkdimþα
Kb
Kbcrep þ 1
 !2
crepctot þ k :¼ kþ;app þ k ðA6Þ
Thus, the observed time constant in the initial phase of the reac-
tion should increase with ctot and α, as was observed in the
experiments.
The dependence on crep is non-monotonous: for Kbcrep bb 1, a linear
increase is expected; for Kbcrep >> 1 a decrease of k+,app according to
1/crep is expected. Thus, at a certain concentration crep the effective dis-
sociation rate (k− = kdim− + koff) will dominate (k− >> k+,app) and
kobs will not depend measurably on crep. The maximal value for k+,app
will be obtained at 1/Kb = crep.
We observe a positive correlation of kobs with crep, indicating
that Kbcrep bb 1. The lowest value of kobs is about 0.01 s−1, thus
k− b 0.01 s−1 corresponding to a half life of 100 s. Since k− =
kdim− + koff we can estimate that the half life of the dimer is longer
than 100 s.
Fit equations for data in Fig. 2
Hyperbolic function
F ¼ Fo
crep
crep þ c50
ðA7ÞHill-Equation
F ¼ Fo
cnrep
cnrep þ cn50
ðA8Þ
Maximal number of toxin monomers per liposome
If we approximate the pore structure by a cylinder with a diameter of
10 nm the area is about 80 nm2. Considering an area of 0.6 nm2 per lipid
(average between POPC and SM, [26]), this corresponds to 130 lipidmol-
ecules, or 16 permonomer (amonomer in the pore structure roughly oc-
cupies 1/8 of the pore structure due to the channel). Thus, if for example
liposomeswith 40% eSMand40% cholesterol are considered,with an eSM
concentration of 2.5 μMin the outer leaﬂet, the total lipid concentration is
3.8 μM,which could accommodate 3.8/16 = 0.24 μM toxin. Here, we as-
sume that cholesterol does not contribute to the lipid area, since it rather
has a condensing effect [30]. At an eSM concentration of 17 µM (compare
Fig. 3) the limiting concentration of bound toxin would be 1.6 µM.
References
[1] I. Iacovache, F.G. van der Goot, L. Pernot, Pore formation: an ancient yet complex
form of attack, Biochim. Biophys. Acta 1778 (2008) 1611–1623.
[2] M.R. Gonzalez, M. Bischofberger, L. Pernot, F.G. van der Goot, B. Freche, Bacterial
pore-forming toxins: the (w)hole story? Cell Mol. Life Sci. 65 (2008) 493–507.
[3] H. Shogomori, T. Kobayashi, Lysenin: a sphingomyelin speciﬁc pore-forming
toxin, Biochim. Biophys. Acta 1780 (2008) 612–618.
[4] K.C. Kristan, G. Viero, M. Dalla Serra, P. Macek, G. Anderluh, Molecular mechanism
of pore formation by actinoporins, Toxicon 54 (2009) 1125–1134.
[5] B. Bakrac, I. Gutierrez-Aguirre, Z. Podlesek, A.F. Sonnen, R.J. Gilbert, P. Macek, J.H.
Lakey, G. Anderluh, Molecular determinants of sphingomyelin speciﬁcity of a
eukaryotic pore-forming toxin, J. Biol. Chem. 283 (2008) 18665–18677.
[6] M. Watanabe, T. Tomita, T. Yasuda, Membrane-damaging action of staphylococcal
alpha-toxin on phospholipid-cholesterol liposomes, Biochim. Biophys. Acta 898
(1987) 257–265.
[7] S. Galdiero,M. Galdiero, C. Pedone, beta-Barrelmembrane bacterial proteins: structure,
function, assembly and interaction with lipids, Curr. Protein Pept. Sci. 8 (2007) 63–82.
[8] L. Song, M.R. Hobaugh, C. Shustak, S. Cheley, H. Bayley, J.E. Gouaux, Structure of
staphylococcal alpha-hemolysin, a heptameric transmembrane pore, Science
274 (1996) 1859–1866.
[9] S. Galdiero, E. Gouaux, High resolution crystallographic studies of alpha-hemolysin-
phospholipid complexes deﬁneheptamer-lipid head group interactions: implication
for understanding protein-lipid interactions, Protein Sci. 13 (2004) 1503–1511.
[10] A. Hildebrand, M. Pohl, S. Bhakdi, Staphylococcus aureus alpha-toxin. Dual mech-
anism of binding to target cells, J. Biol. Chem. 266 (1991) 17195–17200.
[11] I. Maharaj, H.B. Fackrell, Rabbit erythrocyte band 3: a receptor for staphylococcal
alpha toxin, Can. J. Microbiol. 26 (1980) 524–531.
[12] S. Pany, R. Vijayvargia, M.V. Krishnasastry, Caveolin-1 binding motif of alpha-
hemolysin: its role in stability and pore formation, Biochem. Biophys. Res. Commun.
322 (2004) 29–36.
[13] G.A. Wilke, J.B. Wardenburg, Role of a disintegrin and metalloprotease 10 in
Staphylococcus aureus alpha-hemolysin-mediated cellular injury, Proc. Natl.
Acad. Sci. U. S. A. 107 (2010) 13473–13478.
[14] A. Valeva, N. Hellmann, I. Walev, D. Strand, M. Plate, F. Boukhallouk, A. Brack, K.
Hanada, H. Decker, S. Bhakdi, Evidence that clustered phosphocholine head
groups serve as sites for binding and assembly of an oligomeric protein pore,
J. Biol. Chem. 281 (2006) 26014–26021.
[15] A. Valeva, J. Pongs, S. Bhakdi, M. Palmer, Staphylococcal alpha-toxin: the role of
the N-terminus in formation of the heptameric pore — a ﬂuorescence study,
Biochim. Biophys. Acta 1325 (1997) 281–286.
[16] M. Schwiering, N. Hellmann, Validation of liposomal lipid composition by thin
layer chromatography, J. Liposome Res. 22 (2012) 279–284.
[17] A.G. Therien, C.M. Deber, Interhelical packing in detergent micelles. Folding of a
cystic ﬁbrosis transmembrane conductance regulator construct, J. Biol. Chem.
277 (2002) 6067–6072.
[18] U.K. Laemmli, Cleavage of structural proteins during the assembly of the head of
bacteriophage T4, Nature 227 (1970) 680–685.
[19] D.H. Kang, Y.S. Gho, M.K. Suh, C.H. Kang, Highly sensitive and fast protein detec-
tion with coomassie brilliant blue in sodium dodecyl sulfate-polyacrylamide gel
electrophoresis, Bull. Kor. Chem. Soc. 23 (2002) 1511–1512.
[20] T. Baumgart, G. Hunt, E.R. Farkas, W.W. Webb, G.W. Feigenson, Fluorescence
probe partitioning between Lo/Ld phases in lipid membranes, Biochim. Biophys.
Acta 1768 (2007) 2182–2194.
[21] T.Y. Wang, J.R. Silvius, Cholesterol does not induce segregation of liquid-ordered
domains in bilayers modeling the inner leaﬂet of the plasma membrane, Biophys.
J. 81 (2001) 2762–2773.
[22] B. Vecsey-Semjen, R. Mollby, F.G. van der Goot, Partial C-terminal unfolding is
required for channel formation by staphylococcal alpha-toxin, J. Biol. Chem. 271
(1996) 8655–8660.
1972 M. Schwiering et al. / Biochimica et Biophysica Acta 1828 (2013) 1962–1972[23] T. Tomita, M. Watanabe, T. Yasuda, Inﬂuence of membrane ﬂuidity on the assem-
bly of Staphylococcus aureus alpha-toxin, a channel-forming protein, in liposome
membrane, J. Biol. Chem. 267 (1992) 13391–13397.
[24] R. Olson, H. Nariya, K. Yokota, Y. Kamio, E. Gouaux, Crystal structure of staphylo-
coccal LukF delineates conformational changes accompanying formation of a
transmembrane channel, Nat. Struct. Biol. 6 (1999) 134–140.
[25] J.R. Thompson, B. Cronin, H. Bayley, M.I. Wallace, Rapid assembly of a multimeric
membrane protein pore, Biophys. J. 101 (2011) 2679–2683.
[26] G.J. Nelson, Lipid composition of erythrocytes in various mammalian species,
Biochim. Biophys. Acta 144 (1967) 221–232.[27] J.A. Virtanen, K.H. Cheng, P. Somerharju, Phospholipid composition of the mamma-
lian red cell membrane can be rationalized by a superlattice model, Proc. Natl.
Acad. Sci. U. S. A. 95 (1998) 4964–4969.
[28] D. Hegner, D. Platt, H. Heckers, U. Schloeder, V. Breuninger, Age-dependent
physiochemical and biochemical studies of human red cell membranes, Mech.
Ageing Dev. 10 (1979) 117–130.
[29] V.T. Nguyen, Y. Kamio, H. Higuchi, Single-molecule imaging of cooperative assembly
of gamma-hemolysin on erythrocyte membranes, EMBO J. 22 (2003) 4968–4979.
[30] G. Lindblom, G. Oradd, Lipid lateral diffusion and membrane heterogeneity,
Biochim. Biophys. Acta 1788 (2009) 234–244.
